300957 Stock Overview
Yunnan Botanee Bio-Technology Group Co.LTD manufactures and sells skincare products in China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Yunnan Botanee Bio-Technology Group Co.LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥56.13 |
| 52 Week High | CN¥117.75 |
| 52 Week Low | CN¥51.50 |
| Beta | 0.38 |
| 1 Month Change | -9.95% |
| 3 Month Change | -10.79% |
| 1 Year Change | -49.13% |
| 3 Year Change | -73.89% |
| 5 Year Change | n/a |
| Change since IPO | -65.53% |
Recent News & Updates
Shareholder Returns
| 300957 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 0.4% | 0.3% | -0.4% |
| 1Y | -49.1% | -27.3% | -16.2% |
Return vs Industry: 300957 underperformed the CN Personal Products industry which returned -27.3% over the past year.
Return vs Market: 300957 underperformed the CN Market which returned -16.2% over the past year.
Price Volatility
| 300957 volatility | |
|---|---|
| 300957 Average Weekly Movement | 6.0% |
| Personal Products Industry Average Movement | 6.4% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300957 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300957's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 3,053 | n/a | www.botanee.com.cn |
Yunnan Botanee Bio-Technology Group Co LTD manufactures and sells skincare products in China. The company was founded in 2010 and is based in Kunming, China.
Yunnan Botanee Bio-Technology Group Co.LTD Fundamentals Summary
| 300957 fundamental statistics | |
|---|---|
| Market cap | CN¥23.78b |
| Earnings (TTM) | CN¥1.11b |
| Revenue (TTM) | CN¥5.55b |
21.4x
P/E Ratio4.3x
P/S RatioIs 300957 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300957 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.55b |
| Cost of Revenue | CN¥1.40b |
| Gross Profit | CN¥4.15b |
| Other Expenses | CN¥3.04b |
| Earnings | CN¥1.11b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 2.63 |
| Gross Margin | 74.79% |
| Net Profit Margin | 20.06% |
| Debt/Equity Ratio | 0% |
How did 300957 perform over the long term?
See historical performance and comparison